cisplatin/cyclophosphamide/doxorubicin/fluorouracil protocol

Known as: CDDP/CTX/DOX/5-FU, Cisplatin/Cyclophosphamide/Doxorubicin/Fluorouracil, FACP 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2018
0519892018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
This article serves as aCME available, enduring material summary of the following COPD9USA presentations: "Lung Volume Reduction… (More)
Is this relevant?
2014
2014
Center (POIC)-Based Outpatient Treatment with Intravenous Antibiotics (IVABs) Fernando S. Alvarado, MD, MPH, TM; Brian Metzger… (More)
Is this relevant?
2014
2014
Gerald S. Davis, MD, FACP, FACCP, is a Professor of Medicine with tenure at the University of Vermont College of Medicine and… (More)
Is this relevant?
2014
2014
16 June/July 2014 Today’s Wound Clinic® Chronic wounds clearly represent a healthcare burden of tremendous magnitude as they… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
WRITING COMMITTEE MEMBERS* Patrick T. O’Gara, MD, FACC, FAHA, Chair†; Frederick G. Kushner, MD, FACC, FAHA, FSCAI, Vice Chair… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2013
2013
Myelodysplastic syndromes (MDS) represent a collection of heterogeneous malignant bone marrow stem cell disorders that result in… (More)
  • table 2
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Review
2010
Review
2010
Maen Hussein, MD, and Rami Y. Haddad, MD, FACP nemia is one of the most common blood diseases. The number of visits o physician… (More)
Is this relevant?
2004
2004
  • James Liao
  • Journal of investigative medicine : the official…
  • 2004
 
Is this relevant?
2001
2001
Type 2 iodothyronine deiodinase (D2) catalyzes intracellular 3, 5, 39 triiodothyronine (T3) production from thyroxine (T4), and… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?